寡霉素A

寡霉素A性质、用途与生产工艺

生物活性

靶点

体外研究

Oligomycin A是ATP合成酶的抑制剂，抑制氧化磷酸化和所有发生在线粒体耦合膜的ATP依赖性过程。 Oligomycin A通过阻断其质子通道(Fo 亚基)抑制ATP合成， 这对ADP通过氧化磷酸化转化为ATP是必要的。Oligomycin A对ATP合成的抑制会显著降低通过电子传递链的电子流；然而，由于质子泄漏或者线粒体解偶联过程，电子流不会完全停止。在一组癌细胞中，100纳克/毫升的Oligomycin在1小时内完全抑制氧化磷酸化活性，并且经过6小时引起不同程度的糖酵解。 Oligomycin，F0部分H Oligomycin抑制黑色素瘤中线粒体的呼吸作用，使黑色素瘤对治疗敏感，并阻断慢循环、长期肿瘤维持的黑色素瘤细胞的出现。

寡霉素A 上下游产品信息

上游原料

下游产品

寡霉素A 生产厂家

579-13-5, 寡霉素A 相关搜索:

• API
• Spectrum of Activity
• Mechanism of Action
• Macrolides
• Chemical Structure Class
• Antibiotics N-SAntibiotics
• Antibiotics by Application
• Antibiotics A to
• Inhibits an EnzymeAntibiotics
• Antineoplastic and Immunosuppressive AntibioticsAntibiotics
• AntifungalAntibiotics
• Antibiotics
• antibiotic
• Inhibitors
• 化学试剂
• 试剂盒-细胞分析试剂盒
• 小分子抑制剂，天然产物
• 抗生素
• 生化试剂
• 微生物代谢物
• BioChemical
• Antibiotics A to Z
• Antibiotics N-S
• Antibiotics
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-乙基-7,11,14,15-四羟基-6'-((R)-2-羟基丙基)-5',6,8,10,12,14,16,28,29-九甲基-3',4',5',6'-四氢-2,26二氧杂螺[双环[23.3.1]二十九烷[4,18,20]三烯-27,2'-吡喃]-3,9,13-三酮
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-乙基-7,11,14,15-四羟基-6'-((R)-2-羟基丙基)-5',6,8
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-乙基-7,11,14,15-四羟基-6'
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-乙基-7,11,14,15-四羟基-6'-((R)-2-羟基丙基)-5',6,8,10,12,14,16,28,29-九甲基-3',4',5',6'-四氢-2,26二氧杂螺[双环[23.3.1]二十九烷[4,18,20]三烯-27,2'-吡喃]-3,9,13-三酮
• 寡霉素 A,来源于链霉素
• 寡霉素A, 来源于淀粉酶产色链霉菌
• 寡素A
• 寡黴素A
• 寡霉素A
• 579-13-5
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-((R)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosa[4,18,20]triene-27,2'-pyran]-3,9,13-trione
• CS-1898
• OLIGOMYCIN COMPLEX
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-((R)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosa[4,18,20]triene-27,2'-
• (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-((R)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosa[4,18,20]triene-27,2'-pyran]-3,9,13-trione
• OLIGOMYCIN A USP/EP/BP
• Oligomycin A from Streptomyces
• Oligomycin A, 99%, from Streptomyces diastatochromogenes
• Oligomycin A, >=98%
• Oligomycin A MCH 32
• Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,9,13-trione, 22-ethyl-3',4',5',6'-tetrahydro-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-, (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-
• Spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-[2H]pyran]-3,9,13-trione,22-ethyl-3',4',5',6'-tetrahydro-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-,(1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16
• Oli
• mycin A
• AOligoMyci
• MCH 32
• (1R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,27R,28S,29R)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonaMethyl-3',4',5',6'-tetrahydro-3H,9H,13H-spiro[2,26-dioxabicyclo[23.3.1]nonaco
• (1R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,27R,28S,29R)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-3H,9H,13H-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-pyran]-3,9,13-trione
• Oligomycin A fromStreptomyces diastatochromogenes
• OLIGOMYCIN, STREPTOMYCES DIASTATOCHROMOGENES
• OLIGOMYCIN A
• OLIGOMYCIN A, STREPTOMYCES DIASTATOCHROMOGENES